You are viewing an incomplete version of our website. Please click to reload the website as full version.
1st & 2nd October 2013, Marriott Hotel, Regents Park, London

The 4th Annual Biosimilars & Biobetters 2013

Building unto the success of last year, Biosimilars & Biobetters 2013 will showcase how biological therapeutics promises to be a radical step forward for many pharmaceutical companies pipelines, looking at how patent expiry dates are playing an important role in why many Pharma companies are pushing for innovative steps to be taken in this field.

The agenda aims to bring together pharma, biotech, CROs with regulatory bodies and legal experts explaining the advantages and disadvantages within this growing market, looking at case studies from those who are developing and distributing follow on biologics with analysis of key trends in biologic pipelines, methods in clinical trials for biosimilar approval, a review of emerging markets, assessment of biosimilar manufacturing, post approval strategy and future forecasting for follow on biologics.


www.smi-online.co.uk/goto/2013biosimilars-biobetters37.asp